Xiaoguang Qiu
Beijing Tiantan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xiaoguang Qiu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:25 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06105619 · A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).Beijing Pearl Biotechnology Limited Liability Company · active not recruiting · Glioblastoma · principal investigator
- Ph3NCT04532229 · Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in ChildrenBiotech Pharmaceutical Co., Ltd. · unknown · Diffuse Intrinsic Pontine Glioma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 12:25 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.J Neurooncol · 2013137 citationsRCR 4.1
- 3 citationsRCR 0.7
- [Preliminary clinical evaluations of bevacizumab for recurrent malignant glioma in Chinese patients].Zhonghua Yi Xue Za Zhi · 20141 citationsRCR 0.0